Studies on the biochemical actions of 6-selenoguanine and 6-selenoguanosine.
D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism* / Q000627:therapeutic use; D004912:Erythrocytes / Q000201:enzymology; D005260:Female; D005964:Glucosyltransferases / Q000378:metabolism; D006147:Guanine / Q000378:metabolism* / Q000627:therapeutic use / Q000031:analogs & derivatives; D006150:Guanine Nucleotides / Q000096:biosynthesis; D006151:Guanosine / Q000378:metabolism* / Q000627:therapeutic use / Q000031:analogs & derivatives; D006801:Humans; D007042:Hypoxanthines; D007700:Kinetics; D051379:Mice; D016566:Organoselenium Compounds; D010430:Pentosyltransferases / Q000378:metabolism; D010770:Phosphotransferases / Q000097:blood; D012510:Sarcoma 180 / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism; D012643:Selenium / Q000378:metabolism* / Q000627:therapeutic use; D013997:Time Factors
D000970:Antineoplastic Agents; D006150:Guanine Nucleotides; D007042:Hypoxanthines; D016566:Organoselenium Compounds; D006151:Guanosine; C009228:6-selenoguanosine; C009227:6-selenoguanine; D006147:Guanine; D005964:Glucosyltransferases; D010430:Pentosyltransferases; D010770:Phosphotransferases; D012643:Selenium